Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Investigator-Masked, Randomized, Parallel-Group Study of the Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis in Subjects With Dry Eye Disease

Trial Profile

An Investigator-Masked, Randomized, Parallel-Group Study of the Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis in Subjects With Dry Eye Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2019

At a glance

  • Drugs Voclosporin (Primary) ; Ciclosporin
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Aurinia Pharmaceuticals
  • Most Recent Events

    • 22 Jan 2019 According to an Aurinia Pharmaceuticals media release, primary endpoint (Drop Discomfort Assessment Visual Analogue Scale(VAS) has not been met.
    • 22 Jan 2019 According to an Aurinia Pharmaceuticals Media Release, Joseph Tauber, head of the renowned Tauber Eye Institute in Kansas city, is the principal investigator of the study.
    • 22 Jan 2019 Results presented in an Aurinia Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top